Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 32

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 32
---
inking Fund or Mandatory Redemption

The Series B Preferred Stock is perpetual
and has no maturity date, and is not subject to any mandatory redemption, sinking fund or other similar provisions. Accordingly, the Series B
Preferred Stock will remain outstanding indefinitely, unless and until we decide to redeem them or they are converted in connection with
a Change of Control (as defined below) by the holders of the Series B Preferred Stock.

Redemption at Our Option

We may, at our option, redeem the Series B Preferred Stock for cash in whole or in part, from time to time, at any time on or after,
2030, upon not less than 30 nor more than 60 days’ notice at a cash redemption price equal to $25.00 per share, plus any accumulated
and unpaid dividends to, but excluding, the date of redemption. Holders of Series B Preferred Stock will have no right to require
the redemption or repurchase of the Series B Preferred Stock. Investors should not expect us to redeem the Series B Preferred
Stock on or after the date such shares become redeemable at our option.

<div align='center'>S-18</div>

If Series B Preferred Stock is to be redeemed,
the notice of redemption shall be given by first class mail to the holders of record of the Series B Preferred Stock to be redeemed,
mailed not less than 30 days nor more than 60 days prior to the date of redemption thereof (provided that, if the shares of Series B
Preferred Stock are held in book-entry form through DTC, we may give such notice in any manner permitted by DTC). Each notice of redemption
will include a statement setting forth: (i) the redemption date, (ii) the number of shares of Series B Preferred Stock
to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from
such holder, (iii) the redemption price and (iv) the place or places where holders may surrender certificates evidencing shares
of Series B Preferred Stock for payment of the redemption price. If notice of redemption of any Series B Preferred Stock has
been given and if the funds necessary for such redemption have been set aside by us for the benefit of the holders of any Series B
Preferred Stock so called for redemption, then, from and after the redemption date, dividends will cease to accrue on such Series B
Preferred Stock, such Series B Preferred Stock shall no longer be deemed outstanding and all rights of